iSpecimen Inc. (ISPC)
About iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.9M
- Net income
- -$10.5M
- Total assets
- $9.5M
- Market cap
- $4.3M
- Gross margin
- 11.2%
- Operating margin
- -465.4%
- Net margin
- -543.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.9M
- Cost of revenue
- $1.7M
- Gross profit
- $215.7K
- Operating expenses
- $9.2M
- Operating income
- -$9.0M
- Net income
- -$10.5M
- EPS (basic)
- $-2.28
- EPS (diluted)
- $-2.28
Balance sheet
- Total assets
- $9.5M
- Current assets
- $7.0M
- Total liabilities
- $6.4M
- Current liabilities
- $6.2M
- Shareholders’ equity
- $3.1M
Cash flow
- Operating cash flow
- -$4.2M
- Investing cash flow
- -$1.0M
- Financing cash flow
- $10.2M
- Net cash flow
- $5.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.3M
- EPS (diluted)
- $-2.28
- Shares outstanding
- 2.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 17, 2021
iSpecimen Inc. (ISPC) Stock Price
- Reported a net loss of $10.5M in FY2025.
- Revenue declined 83% from FY2021 to FY2025.
- Gross margin of 11.2%, net margin -543.7%.
- Trading 97% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review iSpecimen Inc..
Write a review
News about iSpecimen Inc.
News & sentiment via Polygon.io
iSpecimen Inc.: frequently asked questions
Is iSpecimen Inc. an American company?
iSpecimen Inc. is a US-based company headquartered in Woburn, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is iSpecimen Inc. headquartered?
iSpecimen Inc. is headquartered in Woburn, Massachusetts, United States.
Is iSpecimen Inc. publicly traded?
Yes — iSpecimen Inc. is a publicly traded company. Its stock trades under the ticker symbol ISPC on the NASDAQ.
What does iSpecimen Inc. do?
iSpecimen Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
